Irukandji jellyfish

3 years ago by in Featured, Systematics and Taxonomy, Systematics and Taxonomy

jel 2Irukandji jellyfish (/ˌɪrəˈkændʒi/ irr-ə-kan-jee) are tiny and extremely venomous jellyfish that inhabit marine waters of Australia and which are able to fire their stingers into their victim, causing symptoms collectively known as Irukandji syndrome. Its size is roughly no larger than a cubic centimetre (1 cm3). There are three known species of Irukandji: Carukia barnesi and the recently discovered Malo maximus and Malo kingi.

The symptoms of Irukandji syndrome were first documented by Hugo Flecker in 1952 and named after the Irukandji people whose country stretches along the coastal strip north of Cairns, Queensland. The first of these jellyfish, Carukia barnesi, was identified in 1964 by Jack Barnes; in order to prove it was the cause of Irukandji syndrome, he captured the tiny jelly and allowed it to sting him while his son and a lifeguard observed the effects.

Range

Irukandji jellyfish were at one time thought to be in the northern waters of Australia only. Since then, according to a National Geographic documentary on jellyfish, the species has been found in waters as far north as the British Isles, Japan, and the Florida coast of the United States.

Biology

Irukandji jellyfish are very small with a bell about 5 millimetres (0.20 in) to 25 millimetres (0.98 in) wide (or wider) and four long tentacles, which range in length from just a few centimeters up to 1 metre (3.3 ft) in length. The stingers (nematocysts) are in clumps, appearing as rings of small red dots around the bell and along the tentacles.

Very little is known about the life cycle and venom of Irukandji jellyfish. This is partly because they are too small and fragile requiring special handling and containment. Its venom is very powerful, 100 times as potent as that of a cobra and 1,000 times as potent as that of atarantula. Researchers conjecture that its venom possesses such potency to enable it to quickly stun its prey, which consists of small and fast fish. Judging from statistics, it is believed that the Irukandji syndrome may be produced by several species of jellyfish, but only Carukia barnesi and Malo kingi have so far been proven to cause the condition.

Irukandji Syndrome

Irukandji syndrome is produced by a small amount of venom and induces severe pain at various parts of the body (typically excruciating muscle cramps in the arms and legs, severe pain in the back and kidneys, a burning sensation of the skin and face), headaches, nausea, restlessness, sweating, vomiting, an increase in heart rate and blood pressure, and psychological phenomena such as the feeling of impending doom. The syndrome is in part caused by release of catecholamines. The venom contains a sodium channel modulator.

The sting is moderately irritating; the severe syndrome is delayed for 5–120 minutes (30 minutes on average). The symptoms range from hours to weeks, and victims usually require hospitalisation. As with otherbox jellyfish, vinegar will deactivate unfired nematocysts on the skin but has no effect on the venom already in the body. Treatment is symptomatic, with antihistamines and anti-hypertensive drugs used to control inflammation and hypertension; intravenous opiates, such as morphine and fentanyl, are used to control the pain. Magnesium sulfate has been used to reduce pain and hypertension in Irukandji syndrome, although it has had no effect in other cases.

Irukandji are usually found near the coast, attracted by the warmer water, but blooms have been seen as far as five kilometres offshore. When properly treated, a single sting is normally not fatal, but two people in Australia are believed to have died from Irukandji stings in 2002, greatly increasing public awareness of Irukandji syndrome. It is unknown how many other deaths from Irukandji syndrome have been wrongly attributed to other causes. It is also unknown which jellyfish species can cause Irukandji syndrome apart from Carukia barnesi and Malo kingi.

Re love ution